秦安股份(603758.SH):預計未來1年內需向各家銀行申請總額不超8億元綜合授信額度
格隆匯3月25日丨秦安股份(603758.SH)公佈,為進一步滿足公司生產經營和業務發展的需要,結合公司實際情況,預計公司及子公司在未來一年內(至2022年度董事會召開之日)需向各家銀行申請總額不超過人民幣8億元的綜合授信額度,包括但不限於借款、國際/國內保函、信用證、銀行承兑匯票等,並根據授信額度,辦理相關資產的抵押、質押等手續(涉及重大資產抵押、質押,仍應根據公司相關制度履行審批程序)。
授信額度不等於公司的融資金額,實際融資金額應在授信額度內以銀行與公司實際發生的融資金額為準,具體融資金額將視公司運營資金的實際需求來合理確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.